08:50 MAXX BIOSCIENCE<00512> - Results Announcement MAXX Bioscience Holdings Limited announced on 25/04/2005: (stock code: 00512 ) Year end date: 31/12/2004 Currency: HKD Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/01/2004 from 01/01/2003 to 31/12/2004 to 31/12/2003 Note ('000 ) ('000 ) Turnover : 63,162 66,404 Profit/(Loss) from Operations : (140,439) (82,390) Finance cost : (2,731) (3,279) Share of Profit/(Loss) of Associates : (6,072) (1,769) Share of Profit/(Loss) of Jointly Controlled Entities : 0 0 Profit/(Loss) after Tax & MI : (130,219) (88,156) % Change over Last Period : N/A % EPS/(LPS)-Basic (in dollars) : (0.65) (0.60) -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : (130,219) (88,156) Final Dividend : NIL NIL per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : N/A Payable Date : N/A B/C Dates for Annual General Meeting : 27/06/2005 to 30/06/2005 bdi. Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. TURNOVER Turnover 2004 2003 HK$'000 HK$'000 Sale of health products 38,834 60,252 Sale of health drinks 3,694 4,789 Sale of pharmaceutical products - 1,363 Proceeds from sale of investment in securities 20,634 - ---------- ---------- 63,162 66,404 ========== ========== 2. LOSS PER SHARE The calculation of basic loss per share is based on the loss of HK$130, 219,000 (2003: HK$88,156,000) and on the weighted average of 199,857,663 (2003: 147,617,207) ordinary shares outstanding during the year. The comparative amount for basic loss per share has been adjusted for the 3 for 1 open offer and capital reorganisation took place during the year. Diluted loss per share for the year ended 31 December 2003 and 2004 has not been presented as the potential ordinary shares had an anti-dilutive effect on the basic loss per share for both years. For more details, please refer to the press announcement today.